Tamoxifen Citrate in Patients With Breast Cancer

NCT00963209 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: tamoxifen citrate
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Centre Hospitalier Universitaire Vaudois